抗NT5C1A自身抗体与幼年型肌炎患者更严重疾病相关
研究筛查380例幼年型肌炎、30例幼年特发性关节炎(JIA)和92名健康对照儿童血清中抗NT5C1A自身抗体,比较抗体阳性与阴性肌炎患者的临床特征。结果显示27%幼年型肌炎患者和27%JIA患儿抗体阳性,均高于健康对照的12%。抗体阳性肌炎患者诊断时肺部症状更多、住院更频繁、所需药物种类更多。
要点
- 27%幼年型肌炎和27%JIA患儿抗NT5C1A抗体阳性,健康对照仅12%。
- 抗体阳性肌炎患者诊断时肺部症状更多、住院更频繁、所需药物种类更多。
- 抗体阳性与阴性肌炎患者临床表型相似,但抗体阳性者疾病更严重。
核心结论
- 抗NT5C1A自身抗体存在于超过四分之一的幼年型肌炎和JIA患儿中,而健康儿童仅12%,提示该抗体在儿童中与肌炎相关。
- 与成人IBM类似,抗NT5C1A自身抗体阳性的幼年型肌炎患者疾病更严重。
研究设计与样本
- 研究筛查380例幼年型肌炎患者、30例JIA患者和92名健康对照儿童的血清中抗NT5C1A自身抗体,并比较肌炎患者中有无抗NT5C1A自身抗体的临床特征。
主要发现
- 102/380(27%)幼年型肌炎患者抗NT5C1A自身抗体阳性,健康对照儿童为11/92(12%),差异有统计学意义(P=0.002)。
- JIA患儿抗NT5C1A自身抗体阳性率为27%,与健康对照比较P=0.05。
- 幼年型皮肌炎患者83/307(27%)和幼年型重叠肌炎患者16/46(35%)抗NT5C1A自身抗体阳性,分别与健康对照比较P<0.01;幼年型多肌炎患者仅3/27(11%)阳性。
- 抗NT5C1A自身抗体阳性与阴性的幼年型肌炎患者临床表型相似,但抗体阳性者诊断时肺部症状更多(P=0.005)、住院更频繁(P=0.01)、所需药物种类更多(P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Autoantibodies recognising cytosolic 5'-nucleotidase 1A (NT5C1A) are found in adult patients with myositis and other autoimmune diseases. They are especially prevalent in adults with inclusion body myositis (IBM), in which they are associated with more severe weakness and higher mortality. This study was undertaken to define the prevalence and clinical features associated with anti-NT5C1A autoantibodies in juvenile myositis. METHODS: We screened sera from 380 patients with juvenile myositis, 30 patients with juvenile idiopathic arthritis (JIA) and 92 healthy control children for anti-NT5C1A autoantibodies. Clinical characteristics were compared between patients with myositis with and without anti-NT5C1A autoantibodies. RESULTS: Anti-NT5C1A autoantibodies were present in 102 of 380 (27%) patients with juvenile myositis and in 11 of 92 (12%) healthy control children (P=0.002) and 27% of children with JIA (P=0.05 vs controls). Sera of 83 of 307 (27%) patients with juvenile dermatomyositis and 16 of 46 (35%) patients with juvenile overlap myositis were anti-NT5C1A autoantibody-positive (P<0.01 vs healthy controls for each), but sera of only 3 of 27 (11%) patients with juvenile polymyositis were anti-NT5C1A-positive. Patients with juvenile myositis with and without anti-NT5C1A autoantibodies had similar clinical phenotypes. However, patients with anti-NT5C1A autoantibody-positive myositis had greater pulmonary symptoms at diagnosis (P=0.005), more frequent hospitalisations (P=0.01) and required a larger number of medications (P<0.001). CONCLUSION: Anti-NT5C1A autoantibodies are present in more than one-quarter of children with juvenile myositis and JIA compared with only 12% of healthy children, suggesting they are myositis-associated in children. As in adults with IBM, patients with juvenile myositis with anti-NT5C1A autoantibodies have more severe disease.
引用
- Yeker RM, Pinal-Fernandez I, Kishi T, et al. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018. PMID: 29363513. doi:10.1136/annrheumdis-2017-212436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。